Han, Xiujun <br/><br/>
Synergistic combination of histone deacetylase inhibitor suberoylanilide hydroxamic acid and oncolytic adenovirus ZD55-TRAIL as a therapy against cervical cancer.  [electronic resource] 

 -  Molecular medicine reports  Jul 2015 
 - 435-41 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-3004 
<br/><br/><label>Standard No.: </label>10.3892/mmr.2015.3355  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--genetics<br/>Animals<br/>Drug Synergism<br/>Female<br/>HeLa Cells<br/>Histone Deacetylase Inhibitors--administration & dosage<br/>Humans<br/>Hydroxamic Acids--administration & dosage<br/>Mice<br/>Oncolytic Virotherapy<br/>Uterine Cervical Neoplasms--drug therapy<br/>Vorinostat<br/>Xenograft Model Antitumor Assays